Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry.

Autor: Eugster PJ; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: philippe.eugster@chuv.ch., Dunand M; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Grund B; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Ivanyuk A; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Fogarasi Szabo N; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Bardinet C; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Abid K; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Buclin T; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Grouzmann E; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland., Chtioui H; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Switzerland.
Jazyk: angličtina
Zdroj: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2022 Oct 01; Vol. 535, pp. 19-26. Date of Electronic Publication: 2022 Aug 10.
DOI: 10.1016/j.cca.2022.08.012
Abstrakt: Serotonin is transformed into melatonin under the control of the light/dark cycle, representing a cornerstone of circadian rhythmicity. Serotonin also undergoes extensive metabolism to produce 5-hydroxyindoleacetic acid (5-HIAA), a biomarker for the diagnosis and monitoring of serotonin secreting neuroendocrine tumors (NETs). While serotonin, melatonin and their metabolites are part of an integrated comprehensive system, human observations about their respective plasma concentrations are still limited. We report here for the first time a multiplex UHPLC-MS/MS assay for the quantification of serotonin, 5-HIAA, 5-hydroxytryptophol (5-HTPL), N-acetyl-serotonin (NAS), Mel, 6-OH-Mel, 5-methoxytryptamine (5-MT), 5-methoxytryptophol (5-MTPL), and 5-methoxyindoleacetic acid (5-MIAA) in human plasma. Analytes were extracted by protein precipitation and solid phase extraction. Plasma concentrations for these analytes were determined in 102 healthy volunteers. The LLOQ of the assay ranges from 2.2 nM for serotonin to 1.0 pM for 6-OH-Mel. This sensitivity enables the quantification of circulating serotonin, 5-HIAA, NAS, Mel, and 5-MIAA, even at their lowest diurnal concentrations. This assay will enable specific, precise and accurate measurement of serotonin, Mel and their metabolites to draw a detailed picture of this complex pineal metabolism, allowing a dynamic understanding of these pathways and providing promising biomarkers and a metabolic signature for serotonin-secreting NETs.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: